Key result
Routine assessment of myocardial viability before revascularization requires further randomized trials to conclusively determine its ability to guide treatment and avoid unnecessary procedures.
Why the study?
Does routine assessment of myocardial viability before revascularization identify patients who benefit most and avoid unnecessary procedures?
Design
Review
Authors
Loading...
Clinicians should await randomized data before routine viability testing; leaves open its role in refining revascularization decisions.
Does routine assessment of myocardial viability before revascularization identify patients who benefit most and avoid unnecessary procedures?
Highlights the need for future randomized trials to determine the value of routine myocardial viability testing prior to revascularization.
Himbert et al. (2010) studied this question. Routine assessment of myocardial viability before revascularization requires further randomized trials to conclusively determine its ability to guide treatment and avoid unnecessary procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: